The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For hypothalamic patients specifically, GH treatment has been shown to decrease BMI and improve body composition, especially when given during childhood (163, 164).”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [163]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features of the metabolic syndrome after childhood craniopharyngioma
Srinivasan, S., Ogle, G. D., Garnett, S. P., Briody, J. N., Lee, J. W., & Cowell, C. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030442 · Cited by 211
THE GROWTH WITHOUT GROWTH HORMONE SYNDROME
Geffner, M. E. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70345-5 · Cited by 108
Research works printed but not linked: 31
- H.L. Muller, Craniopharyngioma. Endocr. Rev. 35, 513–543 (2014) · DOI · Paper page
- H.L. Muller, T.E. Merchant, S. Puget, J.P. Martinez-Barbera, New outlook on the diagnosis, treatment and follow–up of childhood-onset craniopharyngioma. Nat. Rev. Endocrinol. 13, 299–312 (2017) · DOI · Paper page
- C.J. de Vile, D.B. Grant, R.D. Hayward, B.E. Kendall, B.G. Neville, R. Stanhope, Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J. Clin. Endocrinol. Metab. 81, 2734–2737 (1996)
- A. Bereket, W. Kiess, R.H. Lustig et al., Hypothalamic obesity in children. Obes. Rev. 13, 780–798 (2012) · DOI
- H.L. Muller, A. Emser, A. Faldum et al., Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J. Clin. Endocrinol. Metab. 89, 3298–3305 (2004) · DOI · Paper page
- B. Ergun-Longmire, A.C. Mertens, P. Mitby et al., Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J. Clin. Endocrinol. Metab. 91, 3494–3498 (2006) · DOI · Paper page
- J.E. Chaplin, B. Kristrom, B. Jonsson et al., Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children. Horm. Res Paediatr. 75, 291–303 (2011) · DOI · Paper page
- H.L. Muller, Consequences of craniopharyngioma surgery in children. J. Clin. Endocrinol. Metab. 96, 1981–1991 (2011) · DOI · Paper page
- H.L. Muller, U. Gebhardt, C. Teske et al., Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur. J. Endocrinol. 165, 17–24 (2011) · DOI · Paper page
- H.L. Muller, U. Gebhardt, N. Etavard-Gorris et al., Prognosis and sequela in patients with childhood craniopharyngioma – results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin. Padiatr. 216, 343–348 (2004) · DOI
- A. Prader, R.H. Largo, L. Molinari, C. Issler, Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv. Paediatr. Acta Suppl. 52, 1–125 (1989)
- M.F. Rolland-Cachera, T.J. Cole, M. Sempe, J. Tichet, C. Rossignol, A. Charraud, Body Mass Index variations: centiles from birth to 87 years. Eur. J. Clin. Nutr. 45, 13–21 (1991)
- G. Calaminus, S. Weinspach, C. Teske, U. Gobel, Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionnaire. Klin. Padiatr. 212, 211–215 (2000) · DOI
- J.E. Wolff, E. Daumling, A. Dirksen, A. Dabrock, M. Hartmann, H. Jurgens, [Munster Heidelberg Abilities Scale–a measuring instrument for global comparison of illness sequelae]. Klin. Padiatr. 208, 294–298 (1996) · DOI
- H.L. Muller, U. Gebhardt, A. Faldum et al., Functional capacity and body mass index in patients with sellar masses-cross-sectional study on 403 patients diagnosed during childhood and adolescence. Childs Nerv. Sys 21, 539–545 (2005) · DOI
- A.M. Pereira, E.M. Schmid, P.J. Schutte et al., High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin. Endocrinol. 62, 197–204 (2005) · DOI · Paper page
- B. Bulow, R. Attewell, L. Hagmar, P. Malmstrom, C.H. Nordstrom, E.M. Erfurth, Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J. Clin. Endocrinol. Metab. 83, 3897–3904 (1998)
- J.W. Tomlinson, N. Holden, R.K. Hills et al., Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357, 425–431 (2001) · DOI · Paper page
- H.L. Muller, K. Bueb, U. Bartels et al., Obesity after childhood craniopharyngioma–German multicenter study on pre-operative risk factors and quality of life. Klin. Padiatr. 213, 244–249 (2001) · DOI · Paper page
- P. Kendall-Taylor, P.J. Jonsson, R. Abs et al., The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur. J. Endocrinol. 152, 557–567 (2005) · DOI
- H.K. Gleeson, R. Stoeter, A.L. Ogilvy-Stuart, H.R. Gattamaneni, B.M. Brennan, S.M. Shalet, Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J. Clin. Endocrinol. Metab. 88, 3682–3689 (2003) · DOI
- M. Geffner, M. Lundberg, M. Koltowska-Haggstrom et al., Changes in height, weight, and body mass index in children with craniopharyngioma after 3 years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J. Clin. Endocrinol. Metab. 89, 5435–5440 (2004) · DOI
- D.A. Price, P. Wilton, P. Jonsson et al., Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm. Res. 49, 91–97 (1998)
- K.C. Yuen, M. Koltowska-Haggstrom, D.M. Cook et al., Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction. Eur. J. Endocrinol. 169, 511–519 (2013) · DOI
- I.C. Huang, E.A. Shenkman, W. Leite, C.A. Knapp, L.A. Thompson, D.A. Revicki, Agreement was not found in adolescents’ quality of life rated by parents and adolescents. J. Clin. Epidemiol. 62, 337–346 (2009) · DOI
- A. Poretti, M.A. Grotzer, K. Ribi, E. Schonle, E. Boltshauser, Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev. Med. Child. Neurol. 46, 220–229 (2004) · DOI · Paper page
- R.B. Levi, D. Drotar, Health-related quality of life in childhood cancer: discrepancy in parent-child reports. Int. J. Cancer Suppl. 2, 58–64 (1999) · DOI
- Y.H. Vance, R.C. Morse, M.E. Jenney, C. Eiser, Issues in measuring quality of life in childhood cancer: measures, proxies, and parental mental health. J. Child. Psychol. Psychiatry 42, 661–667 (2001) · DOI · Paper page
- J. Verhelst, P. Kendall-Taylor, E.M. Erfurth et al., Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). J. Clin. Endocrinol. Metab. 90, 4636–4643 (2005) · DOI
- J.N. Roemmich, M.G. Huerta, S.M. Sundaresan, A.D. Rogol, Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy. Metabolism 50, 537–547 (2001) · DOI
- K.C. Calman, Quality of Life in cancer patients - an hypothesis. J. Med. Ethics 10, 124–127 (1984) · DOI · Paper page
Cited by
Müller, H. L., Merchant, T. E., Warmuth-Metz, M., Martinez-Barbera, J.-P., & Puget, S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0125-9 · Cited by 515
Self-citationMüller, H. L., Tauber, M., Lawson, E. A., Özyurt, J., Bison, B., Martinez-Barbera, J.-P., Puget, S., Merchant, T. E., & van Santen, H. M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00351-z · Cited by 144
Dextroamphetamine Treatment in Children With Hypothalamic Obesity
van Schaik, J., Welling, M. S., de Groot, C. J., van Eck, J. P., Juriaans, A., Burghard, M., Oude Ophuis, S. B. J., Bakker, B., Tissing, W. J. E., Schouten-van Meeteren, A. Y. N., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.845937 · Cited by 30
van Santen, H. M., & Müller, H. L. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf025 · Cited by 21
Hinton, E. C., Lithander, F. E., Elsworth, R. L., Hawton, K., Narayan, K., Szymkowiak, S., Bedford, H. L., Naeem, N., Elson, R., Taylor-Miller, T., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000530863 · Cited by 12
Metadata
- Authors
- Heinks, K., Boekhoff, S., Hoffmann, A., Warmuth-Metz, M., Eveslage, M., Peng, J., Calaminus, G., & Müller, H. L.
- Venue
- Endocrine
- Published
- 2017-12-11
- Volume
- 59
- Issue
- 2
- Pages
- 364-372
- ISSN
- 1355-008X
- 1559-0100
- Cited by
- 77
- References
- 2
- Language
- en
- Funders
- Deutsche Kinderkrebsstiftung (DKS 2014.13)
- Pfizer (WI178359)
- Lilly Deutschland (MQS440-001-TL4-v3)
- Ferring Pharmaceuticals (CS-10459)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. https://app.cochat.ai/papers/10.1007/s12020-017-1489-9
- The paper
- Heinks, K., Boekhoff, S., Hoffmann, A., Warmuth-Metz, M., Eveslage, M., Peng, J., Calaminus, G., & Müller, H. L. (2018). Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine. https://doi.org/10.1007/s12020-017-1489-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.